Oasis Tears Pf Plus

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of burning and irritation associated with dryness of the eye. It is also indicated for the temporary relief of discomfort resulting from minor irritations of the eye, including those caused by exposure to wind or sun. Additionally, this drug serves as a protectant against further irritation and aids in relieving dryness of the eye.

Dosage and Administration

Healthcare professionals are advised to instill 1 or 2 drops of the medication in the affected eye(s) as needed. The frequency of administration should be determined based on the clinical condition of the patient and the response to treatment. It is important to ensure that the drops are administered in a sterile manner to prevent contamination.

Contraindications

Use of this product is contraindicated in the following situations:

• If the solution changes color or becomes cloudy, as this may indicate degradation or contamination.

• In individuals with known sensitivity to any ingredient in this product, due to the potential for adverse reactions.

Warnings and Precautions

For external use only. The product should not be utilized if the solution exhibits any changes in color or becomes cloudy. Additionally, individuals with known sensitivities to any ingredient in this formulation should refrain from use.

In the event of experiencing eye pain, alterations in vision, persistent redness or irritation of the eye, or if the condition worsens or persists beyond 72 hours, it is imperative to discontinue use and consult a healthcare professional.

This product must be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Side Effects

Patients should be aware of the following adverse reactions associated with the use of this product.

For external use only, the product should not be used if the solution changes color or becomes cloudy, or if the patient is sensitive to any ingredient in the formulation. During use, it is important to avoid contamination by not touching the tip of the container to any surface, and to replace the cap after each use. The product should be discarded 90 days after opening to ensure safety and efficacy.

Patients are advised to stop using the product and consult a doctor if they experience any of the following: eye pain, changes in vision, continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

Additionally, the product should be kept out of reach of children. In the event of accidental ingestion, medical help should be sought immediately, or the patient should contact a Poison Control Center.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Oasis Tears Pf Plus (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of Oasis Tears PF Plus Preservative-Free Lubricant Eye Drops during pregnancy. The drug insert does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when considering this product for use in pregnant women, as the potential effects on fetal outcomes are not established. It is advisable to weigh the benefits against any unknown risks when prescribing this medication to women of childbearing potential.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed to monitor the solution for any changes in color or clarity, as these may indicate that the product is no longer safe to use. It is important to discuss the potential for sensitivity to any ingredient in the product; patients should be encouraged to report any known allergies.

Healthcare providers should counsel patients to seek medical attention if they experience eye pain, changes in vision, or persistent redness or irritation of the eye. Patients should be advised to contact their healthcare provider if their condition worsens or does not improve within 72 hours.

To prevent contamination, patients should be instructed not to touch the tip of the container to any surface. Remind patients to replace the cap securely after each use and to discard the product 90 days after opening to ensure safety and efficacy.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers. It is essential to protect the product from light and freezing conditions. The recommended storage temperature range is between 41°F (5°C) and 77°F (25°C). Proper handling and storage are crucial to maintain the integrity of the product.

Additional Clinical Information

Patients should instill 1 or 2 drops in the affected eye(s) as needed. No further information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Oasis Tears Pf Plus, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)